-
Amitifadine (developmental code
names DOV-21,947, EB-1010) is a serotonin–norepinephrine–dopamine
reuptake inhibitor (SNDRI) or so-called
triple reuptake...
- (−)-enantiomer of DOV-216,303, and its (+)-enantiomer is DOV-21,947 (
amitifadine).
Instead of
being developed for depression, DOV-102,677 is
being developed...
- f. DOV 102,677)
Cocaine addiction (e.g., indatraline)
Obesity (e.g.,
amitifadine, tesofensine) Attention-deficit
hyperactivity disorder (ADHD) (c.f. NS-2359...
-
trials for a
number of
different applications to
medical conditions.
Amitifadine Bicifadine Dasotraline DOV-216,303
Tesofensine "Neurovance's EB-1020...
-
Bioscience which intended to
continue development of Dov's antidepressant,
amitifadine (DOV 21,947,
renamed EB-1010). Its drug
candidates included: Indiplon...
- and
selective triple reuptake inhibitor. It is
chemically related to
amitifadine and NS-2359 (GSK-372,475).
Until recently,[when?] it was
under development...
-
reuptake inhibitor (SNDRI). It is the
racemic mixture of
amitifadine (DOV-21,947) and its (–)-enantiomer, DOV-102,677. Its IC50
values for...
-
potential for abuse.
Another clinical trial of
liafensine began in 2022.
Amitifadine Ansofaxine "Digest".
Progress in
Neurology and Psychiatry. 17 (5): 41–43...
-
indatraline dichloroisoprenaline sibutramine:
mazindol dichloropane tramadol Amitifadine Diclofensine JNJ-7925476
venlafaxine Like cocaine, (−)-cis-CPCA and (+)-CPCA...
- U-41123F) –
GABAA receptor positive allosteric modulator and
benzodiazepine Amitifadine (DOV-21947; EB-1010) – serotonin, norepinephrine, and
dopamine reuptake...
